PharmaNovia

Copenhagen, Denmark Founded: 2003 • Age: 23 yrs Acquired By Triton Partners
Generic oncology products and antibiotics are manufactured in Copenhagen.

About PharmaNovia

PharmaNovia is a Healthcare company based in Copenhagen (Denmark) founded in 2003, and was acquired by Triton Partners in August 2019. Generic oncology products and antibiotics are manufactured in Copenhagen. The company has 57 employees. PharmaNovia has completed 1 acquisition, including Lamepro. Its Indian entity Pharmanovia India Private Limited reported revenue of β‚Ή30.65 Cr. Its focus areas include Traditional Pharmaceuticals, Generics, Therapeutic Areas and Oncology.

Company details

PharmaNovia was founded in 2003 in Copenhagen, Denmark, and operates as a manufacturer of generic pharmaceuticals. Focus is placed on oncology products, with additional lines in antibiotics and antidotes for heavy metal poisoning. The company, previously known as NordMedica, produces these generics for therapeutic applications. Operations are centered in the pharmaceutical sector, serving global markets from its Danish base.

  • Headquarters Copenhagen, Denmark
  • Employees 57
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pharmanovia.com
  • Social LinkedIn
  • Acquired by Triton Partners (Aug 2019)
  • Legal Name Pharmanovia India Private Limited
  • Date of Incorporation 27 Jun, 2020
  • Jurisdiction Vadodara, Gujarat, India
Key Metrics
  • Indian entity revenue
    ₹30.65 Cr

    FY 2025 · +28% YoY

  • Indian entity net profit
    ₹3.69 Cr

    FY 2025 · 12% margin

  • Indian entity EBITDA
    ₹7.01 Cr

    FY 2025 · 23% margin

  • Investors
  • Employee Count
    57
  • Investments & Acquisitions
  • Acquired by

Investors in PharmaNovia

PharmaNovia has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Triton Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity and debt fund focused on service, healthcare, consumer, and industrial sectors
1997triton-partners.comLondon, United Kingdom
Premium access

Investor details for PharmaNovia

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Pharmanovia India Private Limited (PharmaNovia)

Pharmanovia India Private Limited is the primary company behind PharmaNovia. The board of Pharmanovia India Private Limited currently have 4 directors; the longest-serving is Gurusubramanian Gopalan, appointed in 2020. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Gurusubramanian Gopalan
DIN 07774380
Director27 Jun 20206 yrs 4 moPharmanovia India Private Limited
Amit Vijaykumar Patel
DIN 08884701
Director21 Sep 20206 yrs 2 moPharmanovia India Private Limited
Muzammil Ali Jasnaik
DIN 11116403
Additional Director20 May 20251 yr 6 moPharmanovia India Private Limited
Tarunkumar Satpathy
DIN 11205772
Additional Director22 Jul 20251 yr 4 moPharmanovia India Private Limited

People of PharmaNovia

19 people are tracked at PharmaNovia (9 in leadership, 10 in team); the tracked headcount is 57.

NameRoleGroup
Steve Deacon
Chief Scientific OfficerLeadership
Alison Dyson
Director Of CommunicationsLeadership
Dr. James Burt
Chief Executive OfficerLeadership
Shiraz Omar
Chief Integration And Procurement OfficerLeadership
Chris Evans
Director, Quality OperationsLeadership
Hashim Hashim
Vice President Of Product DevelopmentLeadership
Suresh Jassel
A Vice President Quality & PharmacovigilanceLeadership
James Lee
Chief Brand OfficerLeadership
Martin S.
Vice President, Global Head Of Strategic Marketing & Commercial ExcellenceLeadership
Chirayu Olkar
Senior Executive, Supply ChainTeam
Roshan Rathnasekara
Supply Chain Senior Manager - External ManufacturingTeam
Apitha Sugumar
Supply Chain Logistics And Customs Senior ManagerTeam
Rebekah Zachej
Global Brand Manager EndocrinologyTeam
Parvez Ghodiwala
Senior Supply Chain ManagerTeam
Vibeke Bro Pedersen
Global Brand Manager, OncologyTeam
Angelique E.
Quality And Technical ManagerTeam
Mahmoud Alghanim
Key Account ManagerTeam
Sriram Pathmarajah
Associate Manager, Global ProcurementTeam
Claire S.
Senior Manager- Supply Chain SupportTeam
Premium access

Complete people profiles for PharmaNovia

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of PharmaNovia

Figures of Pharmanovia India Private Limited, the primary company behind PharmaNovia, for FY 2025. Revenue was ₹30.65 Cr (+28% year on year). Net profit was ₹3.69 Cr (12% margin). EBITDA was ₹7.01 Cr (23% margin). Revenue has grown at a compounded annual rate of +41% over three years.

  • ₹30.65 CrRevenue · FY 2025 · +28% YoY
  • ₹3.69 CrNet profit · 12% margin
  • ₹7.01 CrEBITDA · 23% margin
  • ₹12.51 CrPaid-up capital
  • 57Employees (provident fund records)
  • +41%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Pharmanovia India Private Limited are on its company page.

Premium access

Detailed financial statements for PharmaNovia

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PharmaNovia

PharmaNovia has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lamepro.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Pharmaceutical products for multiple disease treatments are provided.
lamepro.nlNetherlands0Mar 2022β€’β€’β€’β€’
Premium access

Complete acquisition details for PharmaNovia

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of PharmaNovia

3 dated milestones of PharmaNovia across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded PharmaNovia is founded.
  2. Exit Acquired by Triton Partners.
  3. Acquisition Acquires Lamepro.

Web traffic of PharmaNovia

The website of PharmaNovia (pharmanovia.com) receives about 4.6K visits a month and ranks #3,910,190 among all websites worldwide, #4,955 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    4.6K

    ▼ 1.5% vs previous month

  • Unique visitors
    2K

    per month

  • Global rank
    #3,910,190

    among all websites

  • Category rank
    #4,955

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with PharmaNovia. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
pharmaphorum.com
100%
128.2K#451,885View details
pmcpa.org.uk
100%
#2,335,332View details
parkinsons.org.uk
60%
#163,700View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pharmanovia

Premium access

Complete news archive for PharmaNovia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PharmaNovia

PharmaNovia was founded in 2003.

PharmaNovia is headquartered in Copenhagen, Denmark.

PharmaNovia has 57 employees.

The primary company behind PharmaNovia, Pharmanovia India Private Limited, reported revenue of β‚Ή30.65 Cr for FY 2025, up 28% year on year.

PharmaNovia was founded in 2003 in Copenhagen, Denmark, and operates as a manufacturer of generic pharmaceuticals. Focus is placed on oncology products, with additional lines in antibiotics and antidotes for heavy metal poisoning. The company, previously known as NordMedica, produces these generics for therapeutic applications. Operations are centered in the pharmaceutical sector, serving global markets from its Danish base.

PharmaNovia has made 1 acquisition, including Lamepro.

PharmaNovia has 1 investor. Key investors include Triton Partners.

PharmaNovia operates through Pharmanovia India Private Limited.

Yes. PharmaNovia was acquired by Triton Partners in August 2019.

The legal entities of PharmaNovia currently have 5 directors, including Nidhi Nidhish Shah, Amit Vijaykumar Patel, Gurusubramanian Gopalan and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available